A partnership strategy
The idea behind Cantargia's business strategy is to develop product candidates on a proprietary basis until an indication of clinical activity has been obtained. The first project to reach a clinical trial is CAN04, with the aim to have a partnership established after completion of the initial phase I/IIa study. Cantargia is, however, also open to collaborations at an earlier stage. Below is an illustration on how Cantargias R&D is connected to the strategy for partnership.
Please contact our CEO, Göran Forsberg, for further information or if interested in a collaboration.